JP2014501496A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501496A5
JP2014501496A5 JP2013534446A JP2013534446A JP2014501496A5 JP 2014501496 A5 JP2014501496 A5 JP 2014501496A5 JP 2013534446 A JP2013534446 A JP 2013534446A JP 2013534446 A JP2013534446 A JP 2013534446A JP 2014501496 A5 JP2014501496 A5 JP 2014501496A5
Authority
JP
Japan
Prior art keywords
aurka
gist
years
expression
risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013534446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501496A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/054688 external-priority patent/WO2012052954A1/en
Publication of JP2014501496A publication Critical patent/JP2014501496A/ja
Publication of JP2014501496A5 publication Critical patent/JP2014501496A5/ja
Pending legal-status Critical Current

Links

JP2013534446A 2010-10-20 2011-10-20 消化管間質腫瘍における臨床転帰のシグネチャーおよび消化管間質腫瘍の治療の方法 Pending JP2014501496A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10013806.4 2010-10-20
EP10013806 2010-10-20
PCT/IB2011/054688 WO2012052954A1 (en) 2010-10-20 2011-10-20 Signatures of clinical outcome in gastro intestinal stromal tumors and method of treatment of gastroinstestinal stromal tumors

Publications (2)

Publication Number Publication Date
JP2014501496A JP2014501496A (ja) 2014-01-23
JP2014501496A5 true JP2014501496A5 (cg-RX-API-DMAC7.html) 2016-02-04

Family

ID=44999817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013534446A Pending JP2014501496A (ja) 2010-10-20 2011-10-20 消化管間質腫瘍における臨床転帰のシグネチャーおよび消化管間質腫瘍の治療の方法

Country Status (7)

Country Link
US (1) US20130288250A1 (cg-RX-API-DMAC7.html)
EP (1) EP2630259B8 (cg-RX-API-DMAC7.html)
JP (1) JP2014501496A (cg-RX-API-DMAC7.html)
CA (1) CA2811744A1 (cg-RX-API-DMAC7.html)
DK (1) DK2630259T3 (cg-RX-API-DMAC7.html)
ES (1) ES2541054T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012052954A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3064594A1 (en) 2015-03-06 2016-09-07 Université de Bordeaux Signature of clinical outcome in uterine smooth muscle tumor analysis, and method of diagnosis thereof
KR101860652B1 (ko) 2015-12-23 2018-05-24 연세대학교 산학협력단 위장관 간질 종양 진단용 마커 및 위장관 간질 종양의 진단 방법
JP6965621B2 (ja) * 2017-08-02 2021-11-10 富士通株式会社 検出プログラム、検出方法及び検出装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2491067A1 (en) * 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
JP2008542345A (ja) * 2005-05-28 2008-11-27 アストラゼネカ アクチボラグ キナゾリン類及びオーロラキナーゼ阻害剤としてのその使用
AU2006252629A1 (en) * 2005-05-31 2006-12-07 The Pfahl Family Trust (Dated 9 July 1996) Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
US20080058432A1 (en) * 2006-03-03 2008-03-06 Yixin Wang Molecular assay to predict recurrence of Duke's B colon cancer
WO2008025526A1 (en) * 2006-08-31 2008-03-06 F. Hoffmann-La Roche Ag Indole derivatives, their manufacture and use as pharmaceutical agents
TW200831673A (en) * 2006-12-13 2008-08-01 Oncotherapy Science Inc TTK as tumor marker and therapeutic target for lung cancer
MX2009013729A (es) * 2007-06-14 2010-01-25 Schering Corp Imidazopirazinas como inhibidores de proteina quinasa.
US9101631B2 (en) * 2008-12-12 2015-08-11 Georgetown University Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer

Similar Documents

Publication Publication Date Title
Chen et al. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis
ES2833543T3 (es) Evaluación de la actividad de la ruta de señalización celular de TGF usando modelos matemáticos de la expresión de genes diana
Zhu et al. A long non-coding RNA signature to improve prognosis prediction of gastric cancer
Guo et al. Multiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosis
Vergho et al. Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma
Tian et al. A causal role for circulating miR-34b in osteosarcoma
Farrell et al. The identification of circulating MiRNA in bovine serum and their potential as novel biomarkers of early Mycobacterium avium subsp paratuberculosis infection
JP2018505658A5 (cg-RX-API-DMAC7.html)
CN105492630A (zh) 使用靶基因表达的数学建模评价pi3k细胞信号传导途径活性
RU2015125575A (ru) Композиции и способы для лечения злокачественной опухоли
CN104024851A (zh) 针对癌症的紫杉醇反应标志物
JP2020535823A (ja) 標的遺伝子発現の数学的モデル化を使用する、jak−stat3細胞シグナル伝達経路活性の評価
JP2017529859A5 (cg-RX-API-DMAC7.html)
CN106897579A (zh) 基于染色体变异指数的新型早期肿瘤标记物及应用
CN106148529A (zh) 与胃癌相关的LncRNA标记物及其专用检测引物、检测方法、试剂盒与应用
CN104046624A (zh) 用于肺癌预后的基因及其应用
JP2022524484A (ja) がん患者の生存率を予測する方法
Zhai et al. Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status
Ferrasi et al. New LncRNAs in chronic hepatitis C progression: from fibrosis to hepatocellular carcinoma
Kim et al. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population
JP2014501496A5 (cg-RX-API-DMAC7.html)
Zhou et al. A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways
CN103911440B (zh) 一种与铂类化疗药物肝脏毒性相关的snp标志物及其应用
CN116386714A (zh) 一种非小细胞肺癌数据的处理方法
CN120853690A (zh) 一种预测性细胞衰老模型的构建方法、设备、介质和程序产品